Colleen Grogan: Big Pharma is wrong. Allowing Medicare to negotiate drug prices won't hinder new cures - West Central Tribune
From the commentary, "It is time we rethink how and when the government communicates the true nature of its role. The public needs to know that it has already invested in new drug development, and the magnitude of that investment, so it can then understand that Medicare price negotiations must take into account public and private investments to ensure a fair return for the American people."